The global alopecia treatment market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. More Info:- https://www.imarcgroup.com/alopecia-treatment-market

1. Global Alopecia
Treatment Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Alopecia Treatment
Market: Global Industry Trends, Share, Size, Growth, Opportunity and
Forecast 2024-2032," the global alopecia treatment market size reached US$
3.3 Billion in 2023.
Alopecia is a medical condition characterized by hair loss, which can occur on
the scalp or other parts of the body. It is caused due to several factors,
including a sedentary lifestyle, unhealthy eating habits, and growing stress
levels. Its treatment is dependent on numerous factors, such as the type of
alopecia areata, patient age, and the extent of hair loss. The treatment aims to
block the immune system attack and stimulate the regrowth of hair.
Various drugs and surgical treatment options, including hair transplantation
and scalp reduction, have been widely adopted for the treatment of alopecia.
Besides, medications including minoxidil or finasteride are also used for
baldness. These medications are formulated to stimulate hair growth or prevent
further hair loss. Besides, phototherapy or low light laser therapy (LLLT) is
gaining traction around the world as it is safer, tolerable, and less invasive
than other treatments.
Request for a PDF sample of this report:
https://www.imarcgroup.com/alopecia -treatment-market/requestsample

4. Report Description
Global Alopecia Treatment Market Trends:
The increasing prevalence of alopecia among the masses is driving the global market. Coupled with this, the rising cases
of polycystic ovary syndrome (PCOS) are contributing to the overall growth of the market. In line with this, stressful
lif estyles, the escalating cases of malnutrition, and the rising number of individuals with certain medical conditions, such
as diabetes, lupus, and persistent weight loss, are catalyzing the increasing risk of hair loss. Moreover, the growing
awareness about hair loss and the availability of various treatment options is impacting the market favorably. Besides,
the availability of advanced treatment options, including platelet-rich plasma (PRP) therapy, mesotherapy, and low-level
laser therapy (LLLT)are acting as another growth-inducing factor. Along with this, the increasing availability of products,
including shampoos, conditioners, and other hair care products that claim to prevent hair loss and promote hair growth is
also contributing to the growth of the alopecia treatment market. Additionally, the introduction of laser caps, helmets,
combs, and bands are influencing the market. Furthermore, several key players are heavily investing in research and
development activities to develop novel treatment options, thus providing a boost to the market. Apart from this, the
increasing availability of advanced treatment options such as stem cell therapy and gene therapy is creating a positive
market outlook. The market is further driven by other factors, such as the increasing availability of advanced treatment
options, continuous improvements in healthcare infrastructure, and increasing concerns among parents about the health
of their children.
Looking forward, the market is anticipated to reach a value of US$ 4.8 Billion by 2032, exhibiting a growth
rate (CAGR) of 4.1% during 2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/alopecia-treatment-market

5. Report
Segmentation
Breakup by Drug Type:
• Minoxidil
• Finasteride
• Others
Breakup by Indication:
• Androgenic Alopecia
• Alopecia Areata
• Alopecia Totalis
• Others
Breakup by Gender:
• Male
• Female
Breakup by Route of Administration:
• Oral

6. Report
Segmentation
• Topical
• Injectable
Breakup by Distribution Channel:
• Hospitals
• Retail Pharmacies
• Online Pharmacies
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Aclaris Therapeutics Inc.
• Cellmid Limited
• Cipla Limited
• Dr. Reddy’s Laboratories Ltd.
• GlaxoSmithKline plc
• HCell Inc.
• Johnson & Johnson
• Merck & Co. Inc.
• Pfizer Inc.
• Taisho Pharmaceutical Holdings Co. Ltd
• Teva Pharmaceutical Industries Ltd.

8. Key Questions
Answered in
the Report
What was the size of the global alopecia treatment market in
2023?
What is the expected growth rate of the global alopecia
treatment market during 2024-2032?
What are the key factors driving the global alopecia treatment
market?
What has been the impact of COVID-19 on the global alopecia
treatment market?
What is the breakup of the global alopecia treatment market
based on the drug type?
What is the breakup of the global alopecia treatment market
based on the indication?
What is the breakup of the global alopecia treatment market
based on gender?

9. Key Questions
Answered in
the Report
What is the breakup of the global alopecia
treatment market based on the route of
administration?
What is the breakup of the global alopecia
treatment market based on the distribution
channel?
What are the key regions in the global alopecia
treatment market?
Who are the key players/companies in the global
alopecia treatment market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Alopecia Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Type
6.1 Minoxidil
6.1.1 Market Trends
6.1.2 Mark et Forecast
6.2 Finasteride
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
6.3 Others
6.3.1 Mark et Trends
6.3.2 Mark et Forecast
7 Mark et Breakup by Indication

11. Table of
Contents
7.1 Androgenic Alopecia
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Alopecia Areata
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
7.3 Alopecia Totalis
7.3.1 Mark et Trends
7.3.2 Mark et Forecast
7.4 Others
7.4.1 Mark et Trends
7.4.2 Mark et Forecast
8 Market Breakup by Gender
8.1 Male
8.1.1 Market Trends
8.1.2 Mark et Forecast
8.2 Female
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
9 Market Breakup by Route of Administration
9.1 Oral
9.1.1 Mark et Trends
9.1.2 Mark et Forecast
9.2 Topical
9.2.1 Mark et Trends
9.2.2 Mark et Forecast
9.3 Injectable
9.3.1 Mark et Trends
9.3.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/alopecia -treatment-market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com